Menu
Currency
GWAS Study

Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease.

Kottyan LC, Davis BP, Sherrill JD et al.

25017104 PubMed ID
GWAS Study Type
9953 Participants
78 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KL
Kottyan LC
DB
Davis BP
SJ
Sherrill JD
LK
Liu K
RM
Rochman M
KK
Kaufman K
WM
Weirauch MT
VS
Vaughn S
LS
Lazaro S
RA
Rupert AM
KM
Kohram M
SE
Stucke EM
KK
Kemme KA
MA
Magnusen A
HH
He H
DP
Dexheimer P
CM
Chehade M
WR
Wood RA
PR
Pesek RD
VB
Vickery BP
FD
Fleischer DM
LR
Lindbad R
SH
Sampson HA
MV
Mukkada VA
PP
Putnam PE
AJ
Abonia JP
ML
Martin LJ
HJ
Harley JB
RM
Rothenberg ME
Chapter II

Abstract

Summary of the research findings

Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder associated with allergic hypersensitivity to food. We interrogated >1.5 million genetic variants in EoE cases of European ancestry and subsequently in a multi-site cohort with local and out-of-study control subjects. In addition to replicating association of the 5q22 locus (meta-analysis P=1.9×10(-16)), we identified an association at 2p23 spanning CAPN14 (P=2.5×10(-10)). CAPN14 was specifically expressed in the esophagus, was dynamically upregulated as a function of disease activity and genetic haplotype and after exposure of epithelial cells to interleukin (IL)-13, and was located in an epigenetic hotspot modified by IL-13. Genes neighboring the top 208 EoE-associated sequence variants were enriched for esophageal expression, and multiple loci for allergic sensitization were associated with EoE susceptibility (4.8×10(-2)<P<5.1×10(-11)). We propose a model to explain the tissue-specific nature of EoE that involves the interplay of allergic sensitization with an EoE-specific, IL-13-inducible esophageal response involving CAPN14.

657 European ancestry cases, 9,296 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

9953
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.